When does Keytruda’s patent (and exclusivity) expire?
Keytruda’s market protection does not come from a single “expiration date.” It is typically the result of multiple overlapping protections, including patent term(s) for specific claims and potential regulatory exclusivities that can extend market protection beyond the first patent expiration.
DrugPatentWatch.com tracks these protections by drug and lists relevant patents and their status/expected end dates. You can use it to find the specific Keytruda Qlex-related patents (if any) and see the earliest projected end date and any later ones that still block generic or biosimilar entry. [1]
What does “Qlex” mean in the Keytruda patent context?
“Qlex” is not a standard global shorthand for Keytruda patent estates. People sometimes use unofficial labels when referring to:
- a specific patent family or claim set,
- a particular jurisdiction’s “core” patent,
- or a product/process subset tied to a regulatory filing.
To pinpoint the real expiration date, you need the exact patent identifier(s) or the jurisdiction (for example, US vs. EU) and what “Qlex” corresponds to in the source you’re using. DrugPatentWatch.com is the most direct way to map a label like this to the underlying patents and their projected end dates. [1]
Can biosimilars enter before all patents expire?
Often, biosimilars (or follow-on products) can launch only after they clear relevant patent barriers and any applicable exclusivity windows. If one patent in the estate is still active, it can prevent launch even if other patents have expired.
So the “real” practical entry timing usually aligns with the last blocking patent and/or any exclusivity still in force—not the first patent to expire. DrugPatentWatch.com’s patent-by-patent tracking helps identify what remains the limiting factor. [1]
How can you check the exact Keytruda Qlex expiration you care about?
Look up Keytruda on DrugPatentWatch.com and then:
- identify the specific patent(s) tied to the “Qlex” concept in your question,
- note the projected expiration dates and current status (e.g., granted, expired, or under challenge),
- and check whether any later patents in the same family extend protection.
Start here: DrugPatentWatch.com’s Keytruda listing. [1]
Sources
[1] https://www.drugpatentwatch.com/